| Financial Year |
September 30 2021 |
| Monetary Funds |
7,386,480.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,351,367.24 |
| Advances to Suppliers |
98,645,425.53 |
| Other Receivables |
230,551,429.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
786,952,971.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,317,338.32 |
| Total Current Assets |
1,129,205,012.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
41,603,188.00 |
| Fixed Assetes |
28,748,965.04 |
| Under-construction Projects |
10,660,258.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,729,701.37 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
83,742,113.07 |
| Total Assets |
1,212,947,125.58 |
| Short-Term Loans |
5,321,589.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
13,472,544.50 |
| Accounts Received In Advance |
68,158,861.69 |
| Employee Compensation Payable |
7,809,778.31 |
| Taxes Payable |
64,769,317.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
252,315,061.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
411,847,152.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
208,030,811.96 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
208,030,811.96 |
| Total Liabilities |
619,877,964.00 |
| Paid-In Capital(Or Share Stock) |
1,491,100,380.00 |
| Capital Surplus |
1,514,975,748.93 |
| Surplus Reserve |
35,700,540.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,559,494,892.87 |
| Minority Stockholder's Interest |
50,551,096.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
542,518,065.46 |
| Owner's Equity（Stockholder's Equity） |
593,069,161.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,212,947,125.58 |
